Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis

Wong, Yu JunYu JunWongNguyen, Vy HVy HNguyenYang, Hwai-IHwai-IYangLi, JieJieLiLe, Michael HuanMichael HuanLeWu, Wan-JungWan-JungWuHan, Nicole XinrongNicole XinrongHanFong, Khi YungKhi YungFongChen, ElizebethElizebethChenWong, ConnieConnieWongRui, FajuanFajuanRuiXu, XiaomingXiaomingXuXue, QiQiXueHu, Xin YuXin YuHuLeow, Wei QiangWei QiangLeowGoh, George Boon-BeeGeorge Boon-BeeGohCheung, RamseyRamseyCheungWong, GraceGraceWongWong, Vincent Wai-SunVincent Wai-SunWongMING-WHEI YUNguyen, Mindie HMindie HNguyen2023-09-282023-09-282023-0722872728https://scholars.lib.ntu.edu.tw/handle/123456789/635872Chronic hepatitis B (CHB) and fatty liver (FL) often co-exist, but natural history data of this dual condition (CHB-FL) are sparse. Via a systematic review, conventional meta-analysis (MA) and individual patient-level data MA (IPDMA), we compared liver-related outcomes and mortality between CHB-FL and CHB-no FL patients.enCirrhosis; Fibrosis; HBsAg seroclearance; Hepatocellular carcinoma; Mortality; Non-alcoholic fatty liver disease[SDGs]SDG3Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysisjournal article10.3350/cmh.2023.0004371577762-s2.0-85165969080https://api.elsevier.com/content/abstract/scopus_id/85165969080